rs17685

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001395413.1(POR):​c.*306G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.28 in 574,552 control chromosomes in the GnomAD database, including 23,649 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.26 ( 5398 hom., cov: 34)
Exomes 𝑓: 0.29 ( 18251 hom. )

Consequence

POR
NM_001395413.1 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -4.47

Publications

75 publications found
Variant links:
Genes affected
POR (HGNC:9208): (cytochrome p450 oxidoreductase) This gene encodes an endoplasmic reticulum membrane oxidoreductase that is essential for multiple metabolic processes, including reactions catalyzed by cytochrome P450 proteins for metabolism of steroid hormones, drugs and xenobiotics. The encoded protein has a flavin adenine dinucleotide (FAD)-binding domain and a flavodoxin-like domain which bind two cofactors, FAD and FMN, that allow it to donate electrons directly from NADPH to all microsomal P450 enzymes. Mutations in this gene cause a complex set of disorders, including apparent combined P450C17 and P450C21 deficiency, amenorrhea and disordered steroidogenesis, congenital adrenal hyperplasia and Antley-Bixler syndrome, that resemble those caused by defects in steroid metabolizing enzymes such as aromatase, 21-hydroxylase, and 17 alpha-hydroxylase. [provided by RefSeq, Aug 2020]
TMEM120A (HGNC:21697): (transmembrane protein 120A) Predicted to enable ion channel activity. Involved in fat cell differentiation; protein heterooligomerization; and protein homooligomerization. Predicted to be located in plasma membrane. Predicted to be active in membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 7-75986787-G-A is Benign according to our data. Variant chr7-75986787-G-A is described in ClinVar as Benign. ClinVar VariationId is 360731.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.345 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PORNM_001395413.1 linkc.*306G>A 3_prime_UTR_variant Exon 16 of 16 ENST00000461988.6 NP_001382342.1
TMEM120ANM_031925.3 linkc.*385C>T downstream_gene_variant ENST00000493111.7 NP_114131.1 Q9BXJ8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PORENST00000461988.6 linkc.*306G>A 3_prime_UTR_variant Exon 16 of 16 1 NM_001395413.1 ENSP00000419970.2 P16435
TMEM120AENST00000493111.7 linkc.*385C>T downstream_gene_variant 1 NM_031925.3 ENSP00000473983.1 Q9BXJ8-1

Frequencies

GnomAD3 genomes
AF:
0.258
AC:
39287
AN:
152006
Hom.:
5388
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.180
Gnomad AMI
AF:
0.344
Gnomad AMR
AF:
0.224
Gnomad ASJ
AF:
0.233
Gnomad EAS
AF:
0.358
Gnomad SAS
AF:
0.347
Gnomad FIN
AF:
0.399
Gnomad MID
AF:
0.212
Gnomad NFE
AF:
0.278
Gnomad OTH
AF:
0.259
GnomAD4 exome
AF:
0.288
AC:
121518
AN:
422428
Hom.:
18251
Cov.:
0
AF XY:
0.291
AC XY:
64066
AN XY:
220346
show subpopulations
African (AFR)
AF:
0.179
AC:
2172
AN:
12142
American (AMR)
AF:
0.217
AC:
3452
AN:
15924
Ashkenazi Jewish (ASJ)
AF:
0.241
AC:
3220
AN:
13346
East Asian (EAS)
AF:
0.361
AC:
10857
AN:
30114
South Asian (SAS)
AF:
0.334
AC:
12544
AN:
37548
European-Finnish (FIN)
AF:
0.387
AC:
11138
AN:
28774
Middle Eastern (MID)
AF:
0.276
AC:
529
AN:
1914
European-Non Finnish (NFE)
AF:
0.274
AC:
70704
AN:
257676
Other (OTH)
AF:
0.276
AC:
6902
AN:
24990
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
4257
8513
12770
17026
21283
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
422
844
1266
1688
2110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.259
AC:
39327
AN:
152124
Hom.:
5398
Cov.:
34
AF XY:
0.266
AC XY:
19788
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.181
AC:
7496
AN:
41512
American (AMR)
AF:
0.224
AC:
3433
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.233
AC:
810
AN:
3472
East Asian (EAS)
AF:
0.358
AC:
1847
AN:
5154
South Asian (SAS)
AF:
0.346
AC:
1670
AN:
4822
European-Finnish (FIN)
AF:
0.399
AC:
4228
AN:
10584
Middle Eastern (MID)
AF:
0.224
AC:
66
AN:
294
European-Non Finnish (NFE)
AF:
0.278
AC:
18914
AN:
67968
Other (OTH)
AF:
0.260
AC:
549
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1548
3096
4644
6192
7740
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
422
844
1266
1688
2110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.265
Hom.:
20662
Bravo
AF:
0.239
Asia WGS
AF:
0.318
AC:
1105
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.66
CADD
Benign
0.039
DANN
Benign
0.86
PhyloP100
-4.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17685; hg19: chr7-75616105; API